Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Feasibility of Daily Low Dose Tadalafil and Subsequent Effects on Cognition and Cerebral Vasomotor Reactivity in Elderly Patients With Mild Cognitive Impairment

NCT07882901 is registered in ClinicalTrials.gov with Los Angeles Brain Science Project as lead sponsor.

NCT NCT07882901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07882901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Feasibility of Daily Low Dose Tadalafil and Subsequent Effects on Cognition and Cerebral Vasomotor Reactivity in Elderly Patients With Mild Cognitive Impairment
Lead sponsor
Los Angeles Brain Science Project
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
February 20, 2027
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment (mci)